A systematic review and meta‐analysis involving 9058 NSCLC patients identified ALK positivity and RET translocation as the most prevalent genomic alterations, accounting for 34.9 and 32.2%, respectively.4 The gene discussed is RET; the disease is non-small cell lung carcinoma.